ArticleThe Journal of clinical investigation2000

A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

M L Boytim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.